Feb 2025 | Federal Ministry of Health
Launch of 30 projects on patient-oriented care
In 2024, the Federal Ministry of Health (BMG) established a funding priority on “investigation and strengthening of needs-based care addressing the long-term health effects of COVID-19 (Long COVID)”. In this context, the BMG has a total of up to 81 million euros at its disposal (from 2024 to 2028) to fund patient-oriented research into Long COVID. In a competitive application process, 30 projects launching late 2024 or early 2025 were selected for funding.
A list of the projects funded can be found on the BMG’s website.
This patient-oriented funding on Long COVID will focus particularly on pilot projects that develop and test innovative types of treatment for people with Long COVID. A network will be created to encourage knowledge exchange, initiate care research and thus improve the care of those affected. The aim is for research findings that can inform the treatment of Long COVID, including ME/CFS associated with Long COVID, to be translated as soon as possible into patient care and, conversely, for data from healthcare to be made available to researchers.
Federal Ministry of Health
The Federal Ministry of Health is on the highest federal agencies of the Federal Republic of Germany. It has its head office or the first office in the city of Bonn and its second office in Berlin. The responsible Federal Minister in the Scholz cabinet is Prof Dr Karl Lauterbach of the SPD, from 8 December 2021.